tiletamine hydrochloride has been researched along with Duncan Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dewan, MZ; Honda, M; Horie, R; Ishida, T; Miyake, A; Sata, T; Umezawa, K; Watanabe, M; Watanabe, T; Yamamoto, N | 1 |
1 other study(ies) available for tiletamine hydrochloride and Duncan Disease
| Article | Year |
|---|---|
Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ.
Topics: Animals; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Benzamides; Cell Line, Tumor; Cell Survival; Cyclohexanones; Herpesvirus 4, Human; Humans; Immunologic Factors; Lymphoproliferative Disorders; Mice; Mice, SCID; NF-kappa B | 2008 |